Biotechnology cancer Clinical Trials drug development Immunotherapies Investigational Drug with Immunotherapy May Provide New Therapeutic Opportunity for Patients Previously Treated for Kidney and Lung Cancer By Staff Reports 3 weeks ago Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may
Biotechnology cancer Clinical Trials drug development Gene Therapy MicroRNA-based Therapy May be New Weapon to Combat Cancer By Staff Reports 4 weeks ago A technology that manipulates microRNAs (miRNAs) developed by Jingfang Ju, PhD, a biochemist and Professor
Biotechnology cancer Clinical Trials drug development New drug shows encouraging survival in pancreatic cancer By Staff Reports 2 months ago A clinical trial testing a new drug in pancreatic cancer had promising initial results, report
Biotechnology drug development genes Pharmaceuticals rare diseases Single Enzyme Helps Drive Inflammation in Mice, Provides Target for New Sepsis Drugs By Staff Reports 2 months ago Sepsis occurs when the body goes overboard in its attempt to fight off an infection.
Biotechnology cancer drug development Hepatitis Study Proves Hepatitis C Drugs Reduce Liver-Related Deaths by Nearly Half By Staff Reports 2 months ago A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for
Biotechnology cancer Cell Therapy Clinical Trials drug development Pancreatic Cancer: Less Toxic, More Enduring Drug May Improve Therapy By Staff Reports 2 months ago Unlike many other cancers, most pancreatic tumors are rock hard. “That’s one reason why pancreatic
cancer Clinical Trials drug development Immunotherapies Zhang group identifies gene that may make triple-negative breast cancer cells vulnerable to existing drug By Staff Reports 3 months ago Certain therapies that have proven effective in treating some types of breast cancers are ineffective
Biotechnology cancer drug development Immunotherapies Scientists develop promising drug for treating ovarian and pancreatic cancers By Staff Reports 3 months ago Known as two of the most lethal cancers, ovarian and pancreatic cancer are often called
Biotechnology drug development Uncategorized Study Shows Experimental Drug Can Encourage Bone Growth in Children with Dwarfism By Staff Reports 4 months ago Researchers at Johns Hopkins Medicine, the Murdoch Children’s Research Institute in Australia and seven other
drug development Health and Wellness Metformin Study Shows Drug Has Promise for Women with PCOS By Staff Reports 4 months ago A new study has shown that Metformin can be an effective treatment for women with Polycystic Ovarian
Biotechnology cancer drug development Immunotherapies UCLA researchers identify three-drug combination that helps curb the growth of deadly type of skin cancer By Staff Reports 4 months ago A UCLA-led research team has pinpointed a three-drug combination that could prove to be an
Diabetes drug development Kidney disease Large international study finds diabetes drug cuts cardiovascular and kidney problems By Staff Reports 4 months ago A clinical trial that followed more than 9,900 people in 24 countries has found that
drug development Infectious Diseases Bacteria-Mimicking Particles May Help Treat Infectious Diseases By Staff Reports 7 months ago Unique particles modified to mimic bacteria may provide a better means of treating infectious diseases,
drug development Dramatic Shifts in First-time Opioid Prescriptions Bring Hope, Concern By Staff Reports 7 months ago A national call for restraint in opioid prescribing has yielded dramatic progress in clinician prescribing
drug development Smokers Are At High Risk for Low Back Pain, Hospitalization and Opioid Use By Staff Reports 8 months ago Smokers are at high risk for low back pain, and also have higher rates of
Biotechnology cancer Cancer Discovery Cell Therapy drug development Anti-Malaria Drugs Have Shown Promise in Treating Cancer, and Now Researchers Know Why By Staff Reports 11 months ago Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until
cancer Clinical Trials drug development Surgery Neoadjuvant Combination Checkpoint Blockade Trial Yields High Response Rates for Patients with High-Risk Stage 3 Melanoma By Staff Reports 1 year ago Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high response rate among patients with
Antibiotics Clinical Trials drug development rare diseases Taking a Pill Can Effectively Treat Brutal Lung Disease By Staff Reports 1 year ago Researchers report in Nature Communications they figured out why air sacs in the lungs clog